Skip to main content

Latest SEC Filings — Page 112

Page 112 · 30 filings scored 7+ · newest 7:00 AM ET · How scores work

Tue, Oct 2019 filings
8SSTISoundThinking, Inc.Transom Opens $8.00 Cash Plus $3.00 CVR Tender Offer for SoundThinkingSchedule TO-T▲ PositivePro8RTXRTX CorpRTX Q3 Sales Up 11% to $25.0B; Raises 2026 EPS and Cash Flow Outlook AgainForm 8-K · Current report▲ PositivePro7KRThe Kroger Co.Kroger Sets New Long-Term Targets: 7%-11% EPS Growth Through 2029, Reaffirms 2026 GuidanceForm 8-K · Current report▲ Positive7HALHalliburton CompanyHalliburton Q3 2026: Adjusted EPS $0.60, Revenue $5.7B, 2027 Margin Outlook ~15%Form 8-K · Current report▲ Positive7MSCIMSCI Inc.MSCI Q3 2026: Revenue Up 12.4%, EPS Up 14.4%, Interest Expense Guidance RaisedForm 8-K · Current report▲ Positive7MMM3M Company3M Beats on Q3, Raises FY26 Adjusted EPS Guidance to $9.10-$9.15Form 8-K · Current report▲ Positive8GEGeneral Electric CompanyGE Aerospace Q3 10-Q: Revenue Up 16%, Adjusted EPS $2.25, RPO $212BForm 10-Q · Periodic report▲ PositivePro8HASHasbro, Inc.Hasbro Beats on Q3, Raises 2026 Outlook and Doubles Buyback TargetForm 8-K · Current report▲ PositivePro7EFXEquifax Inc.Equifax Q3 Revenue Up 10% to $1.69B; FY26 Revenue Guidance Trimmed on Weak Mortgage MarketForm 8-K · Current report● Neutral8GEGeneral Electric CompanyGE Aerospace Q3 Orders Jump 49%, 2026 Guidance Raised Across the BoardForm 8-K · Current report▲ PositivePro8KEYKeyCorpKeyCorp Q3 EPS $0.51 Beats, Record $2.04B Revenue; Lifts Loan Growth OutlookForm 8-K · Current report▲ PositivePro8DCOMDime Commercial Bancshares, Inc.Dime Posts 53% EPS Jump, Record $135M Revenue, and Unveils ES Bancshares DealForm 8-K · Current report▲ PositivePro7PEBOPeoples Bancorp Inc.Peoples Bancorp Q3 EPS $0.91; Adjusted $1.04 Tops Consensus, Dividend Held at $0.42Form 8-K · Current report▲ Positive8LPBBLaunch Two Acquisition Corp.NuCube Lands $25M AIDEA Anchor Investment, Amends SPAC Merger AgreementForm 425 · Proxy▲ PositivePro9RAPPRapport Therapeutics, Inc.Rapport's RAP-219 Clears Phase 2 Bipolar Mania Endpoint, Opening a Second Phase 3 PathForm 8-K · Current report▲ PositivePro7AITXArtificial Intelligence Technology Solutions Inc.AITX Pushes Cash Breakeven to January 2027, Expands Cost Cuts Past $350K/MonthForm 8-K · Current report● Neutral7SYFSynchrony FinancialSynchrony Q3 Earnings Fall 17% to $892M; Credit Improves, FY EPS Outlook ~$9.50Form 8-K · Current report● Neutral7NOCNorthrop Grumman CorporationNorthrop Q3 Beats: Sales Up 7% to $11.1B, Backlog Hits Record $109.6B, 2026 Guidance RaisedForm 8-K · Current report▲ Positive7PACPacific Airport GroupGAP 3Q26: Revenue Up 21.8%, EBITDA Margin Ex-IFRIC-12 Hits 67.8% on CBX ConsolidationForm 6-K · Current report● Neutral
Mon, Oct 1911 filings
7SKKRantizoRantizo Holder Phillip Oldridge Discloses 9.02% Stake, Backs US Redomicile and Board ChangesSchedule 13D · Ownership stake● Neutral7COPLCopley Acquisition CorpCopley Sets Oct 29 Vote on 12-Month Extension After Ignite Deal CollapseDEF 14A · Proxy● Neutral8CABOCable One, Inc.Graham Trusts Complete Exit: Cable One Insider Sells Below 5% as Stock CratersSchedule 13D/A · Ownership stake▼ NegativePro8BCABBioAtla, Inc.BioAtla Registers 8.18M Shares for New $40M Yorkville Standby Equity FacilityForm S-1 · Offering▼ NegativePro8NIMUNon-Invasive Monitoring Systems, Inc.NIMU Halves Gravitics IPO to $50M From $125M, Sets $14-$17/Share RangeForm S-1/A · Offering● NeutralPro8NIMUNon-Invasive Monitoring Systems, Inc.NIMU S-4/A No. 7: Gravitics Merger Terms Finalized, Offering Floor Cut to $40MForm S-4/A● NeutralPro8BCABBioAtla, Inc.BioAtla Signs $40M Yorkville Equity Line, Replacing $15M SEPAForm 8-K · Current report▼ NegativePro8INVInnventure, Inc.Activist Ascent Capital Hits 10.7% of Innventure, Demands NAV Floor on $60M ATMSchedule 13D/A · Ownership stake▲ PositivePro7TALOTalos Energy Inc.Slim Family's Control Empresarial Sells $47.3M of Talos Stock, Stake Down to 16.0%Form 4 · Insider trade▼ Negative9SLGNSilgan Holdings Inc.Silgan Files Definitive Trivium Deal: $1.025B AIP Partner, $4.9B MetalCo Debt, 60/40 VentureForm 8-K · Current report▲ PositivePro8IAMIambic Therapeutics, Inc.Director Buys $11.5M of Iambic Stock at IPO Price; Preferred Converts to CommonForm 4 · Insider trade▲ PositivePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.